NDC 13107-282 – Clorazepate Dipotassium
Clorazepate Dipotassium 3.75 mg/1 · Tablet · Oral
Product NDC13107-282
Product details
- Brand name
- Clorazepate Dipotassium
- Generic name
- Clorazepate Dipotassium
- Labeler
- Aurolife Pharma LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA071858
- Marketed since
- September 23, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Benzodiazepine
Active ingredients
- Clorazepate Dipotassium 3.75 mg/1
Uses, dosage, side effects and warnings for Clorazepate Dipotassium →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 13107-282-01 | 100 TABLET in 1 BOTTLE (13107-282-01) | Sep 23, 2023 |
| 13107-282-05 | 500 TABLET in 1 BOTTLE, PLASTIC (13107-282-05) | Sep 23, 2023 |
Recalls mentioning this NDC
- D-0492-2024 May 15, 2024 · Class II
Discoloration: Dotted and yellow spots on tablets - D-0491-2024 May 15, 2024 · Class II
Discoloration: Dotted and yellow spots on tablets
Other Clorazepate Dipotassium products
- 70954-157 Clorazepate Dipotassium 15 mg/1 · Tablet · ANI Pharmaceuticals, Inc.
- 70954-158 Clorazepate Dipotassium 7.5 mg/1 · Tablet · ANI Pharmaceuticals, Inc.
- 70954-159 Clorazepate Dipotassium 3.75 mg/1 · Tablet · ANI Pharmaceuticals, Inc.
- 60505-4756 Clorazepate Dipotassium 15 mg/mg · Tablet · Apotex Corp.
- 60505-4754 Clorazepate Dipotassium 3.75 mg/mg · Tablet · Apotex Corp.
- 60505-4755 Clorazepate Dipotassium 7.5 mg/mg · Tablet · Apotex Corp.
- 13107-283 Clorazepate Dipotassium 7.5 mg/1 · Tablet · Aurolife Pharma LLC
- 13107-284 Clorazepate Dipotassium 15 mg/1 · Tablet · Aurolife Pharma LLC
- 13107-319 Clorazepate Dipotassium 3.75 mg/1 · Tablet · Aurolife Pharma LLC
- 13107-320 Clorazepate Dipotassium 7.5 mg/1 · Tablet · Aurolife Pharma LLC
- 13107-321 Clorazepate Dipotassium 15 mg/1 · Tablet · Aurolife Pharma LLC
- 58118-4043 Clorazepate Dipotassium 7.5 mg/1 · Tablet · Clinical Solutions Wholesale, LLC